Molecular basis of human angiotensin‐1 converting enzyme inhibition by a series of diprolyl‐derived compounds

Documenti analoghi

• Molecular basis of domain‐specific angiotensin I‐converting enzyme inhibition by the antihypertensive drugs enalaprilat, ramiprilat, trandolaprilat, quinaprilat and perindoprilat
  di: Kyle S. Gregory, et al.
  Pubblicazione: (2025)
• Kinetic and structural characterisation of domain‐specific angiotensin I‐converting enzyme inhibition by captopril, rentiapril and zofenoprilat
  di: Kyle S. Gregory, et al.
  Pubblicazione: (2026)
• HDAC6 inhibition upregulates endothelial SOD3 expression via Sp1 acetylation and attenuates angiotensin II ‐induced hypertension
  di: Zhexi Chi, et al.
  Pubblicazione: (2025)
• A general model for analysis of linear and hyperbolic enzyme inhibition mechanisms
  di: Rafael S. Chagas, et al.
  Pubblicazione: (2025)
• Menthol‐like cooling compounds, including (R)‐(‐)‐carvone, inhibit the human bitter taste receptors for saccharin and acesulfame K
  di: Miyuu Saito, et al.
  Pubblicazione: (2025)